The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour

This publication has 8 references indexed in Scilit:

• Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma
  2010
• Standards for PET Image Acquisition and Quantitative Data Analysis
  Journal of Nuclear Medicine, 2009
• 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma
  2008
• Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trial
  Radiotherapy and Oncology, 2008
• Management of the unknown primary carcinoma: Long‐term follow‐up on a negative PET scan and negative panendoscopy
  Head & Neck, 2007
• 2-Deoxy-2-[F-18]fluoro-d-glucose—Positron Emission Tomography of the Head and Neck: An Atlas of Normal Uptake and Variants
  Molecular Imaging and Biology, 2005
• The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor
  Cancer, 2004
• Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities
  European Journal of Nuclear Medicine and Molecular Imaging, 2002